Dir Dev R&D - Director Dev R&D bei IPSEN: Mitarbeiterbewertung

2.0
18. März 2014
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Can meet very nice people, committed and talented

Kontras

VP and SVPs layers unabling decision making, High politics conflicts, Many coming from mega companies and applying same processes while Ipsen is small and agility is key. Products old with too many emphasis on new molecules rather than LCM, New technology for administering, enabling home hospitalisation, and closing eyes from competition rather than beating them!

Mehr Bewertungen zu IPSEN entdecken

5.0
2. März 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Ipsen continues to offer a mission‑driven environment where teams are genuinely committed to improving outcomes for patients and society, and that sense of purpose shows up in the day‑to‑day culture. Collaboration across functions is strong, and there are meaningful opportunities to contribute to strategy, development, and cross‑functional problem‑solving. We have an amazing team filled with valuable talents.

Kontras

The pace of change and evolving priorities can sometimes create ambiguity, and some processes still require tighter alignment to reduce friction and improve consistency. Development pathways and communication around long‑term strategy can feel uneven depending on the team. However, Ipsen remains a place where impact, collaboration, and purpose are real strengths, with room to continue strengthening operational clarity and consistency as the organization grows, which is an achievement.

1.0
27. Apr. 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Some nice colleagues. Good perks.

Kontras

High leadership turnover and lack of transparency and direction. A few toxic individuals are running the show, promoting inexperienced employees at the expense of competent ones.

2
Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle